CRBP Earnings

Quarterly EPS
$-1.15
Q3 2024
$-0.78
Q4 2024
$-1.39
Q1 2025
$-1.44
Q2 2025
$-1.90
Q3 2025
$-1.24
Q4 2025
$-1.23
Q1 2026
$-1.81
Q2 2026
Latest RevenueN/A
Latest Net Income-35037000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.810-35037000—-25.7%
Q1 2026-$1.230-22969000—+11.5%
Q4 2025-$1.240-20555000—-59.0%
Q3 2025-$1.900-23342000—-65.2%
Q2 2025-$1.440-17662000—-60.0%
Q1 2025-$1.390-16978000—-67.5%
Q4 2024-$0.780-9530000—+56.9%
Q3 2024-$1.150-13783000—+49.3%
Q2 2024-$0.900-9997000——
Q1 2024-$0.830-6899000——
Q4 2023-$1.810-8022000——
Q3 2023-$2.270-10053000——
Corbus Pharmaceuticals (CRBP) — Earnings